Recreational drugs: Current trends in the 90s

Clinics in Laboratory Medicine

Volumn 18, Issue 4, 1998, Pages 727-746

  Ropero Miller, J D ^a   Goldberger, B A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; AMPHETAMINE; FLUNITRAZEPAM; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; OXYBATE SODIUM;

CENTRAL NERVOUS SYSTEM DEPRESSION; DRUG DEPENDENCE; DRUG EFFECT; EUPHORIA; GROUP PSYCHOLOGY; HALLUCINATION; HUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOOTH MUSCLE RELAXATION;

EID: 0031740968     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-2712(18)30148-3     Document Type: Review

References (50)

1. Allen R.P. McCann U.D. Ricaurte G.A. Persistent effects of (± )3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) on human sleep Sleep 16 1993 560
2. Andrews K: The Analysis of GHB and Its Butyrolactone: GHB Workshop, American Academy of Forensic Sciences Annual Meeting. New York, February, 1997
3. Baselt R.C. Cravey R.H. Disposition of Toxic Drugs and Chemicals in Man ed 4. 1995 CTI Foster City, CA
4. Beck O. Lafolie P. Hjemdahl P. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance Clin Chem 38 1992 271
5. Bellet N.F. Scholtz H.A. Opel M.L. High sensitivity CEDIA® DAU benzodiazepine assay utilizing ß-glucuronidase J Anal Toxicol 21 1997 90
6. Boukhabza A. Lugnier A.A.J. Kintz P. Simultaneous HPLC analysis of the hypnotic benzodiazepines nitrazepam, estazolam, flunitrazepam, and triazolam in plasma J Anal Toxicol 15 1991 319
7. Brown E.R.S. Jarvie D.R. Simpson D. Use of drugs at ’raves’ Scott Med J 40 1995 168
8. Budavari S. O’Neil M.J. Smith A. The Merck Index ed 12. 1996 Merck Research Laboratories Whitehouse Station, New Jersey
9. Cano J.P. Guintrand J. Aubert C. Determination of flunitrazepam, desmethylflunitrazepam and clonazepam in plasma by gas liquid chromatography with an internal standard Arz Forsch/Drug Res 27 1977 338
10. Chin M.Y. Kreutzer R.A. Dyer J.E. Acute poisoning from y-hydroxybutyrate in California West J Med 156 1992 380
11. Cody J.T. Detection of D,L-amphetamine, D,L-methamphetamine, and illicit amphetamine analogs using Diagnostic Products Corporation’s amphetamine and metham-phetamine radioimmunoassay J Anal Toxicol 14 1990 321
12. Cox D.E. Williams K.R. ’ADAM’ or ’EVE’?-a toxicological conundrum Forensic Sei Int 77 1996 101
13. Cuomo M.J. Dyment P.G. Gammino V.M. Increasing use of “Ecstasy” (MDMA) and other hallucinogens on a college campus J Am Coll Health 42 1994 271
14. Dowling G.P. McDonough E.T. Bost R.O. ’Eve’ and ’Ecstasy’. A report of five deaths associated with the use of MDEA and MDMA JAMA 257 1987 1615
15. Doherty J.D. Snead O.C. Roth R.H. A sensitive method for quantitation of y-hydroxybutyric acid and y-butyrolactone in brain by electron capture gas chromatography Anal Biochem 69 1975 268
16. Dyer J.E. y-Hydroxybutyrate: a health-food product producing coma and seizurelike activity Am J Emerg Med 9 1991 321
17. Dyer JE, Kreutzer R, Quattrone A, et al: Multistate outbreak of poisonings associated with illicit use of gamma hydroxy butyrate. Morbidity and Mortality Weekly Report 39:861, November 30, 1990
18. Elk C. MDMA (Ecstasy): useful information for health professionals involved in drug education programs J Drug Educ 26 1996 349
19. Ellenhorn M.J. Schonwald S. Ordog G. Drugs of Abuse Ellenhorn M.J. Ellenhorn’s Medical Toxicology: Diagnosis and Treatment of Human Poisoning 2nd ed. 1997 Williams and Wilkins Baltimore
20. ElSohly M.A. Feng S. Salamone S.J. GC-MS procedure for the analysis of flunitrazepam and its metabolites in urine J Anal Toxicol 21 1997 80
21. Fact Sheet: GHB. U.S. Department of Justice, Drug Enforcement Administration, Public Affairs Section. October, 1996
22. Ferrara S.D. Tedeschi L. Frison G. Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography-mass spectrometry J Pharm Biomed Anal 11 1993 483
23. Flunitrazepam. DEA Highlights-1995 http://www.usdoj.gov/dea/pubs/rohypnol/ro-hypnol.htm
24. Forrest A.R. Galloway J.H. Marsh I.D. A fatal overdose with 3,4-methylenedioxyamphetamine derivatives Forensic Sei Int 64 1994 57
25. Gan B.K. Baugh D. Liu R.H. Walia A.S. Simultaneous analysis of amphetamine, metham-phetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in urine samples by solid-phase extraction, derivatization, and gas chromatography/mass spectrometry J Forensic Sei 36 1991 1331
26. Hoffmann-LaRoche Flunitrazepam Information Hotline (1-800-720-1076)
27. Huang W. Moody D.E. Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood J Anal Toxicol 19 1995 333
28. Johnson R.H. Bussey J.L. Assay procedure for the sodium salt of gamma hydroxybutyric acid: Laboratory Information Bulletin No 3532. Department of Health and Human Services, Public Health Service, Food and Drug Administration. 7 1991 1
29. Jones G.R. Benzodiazepines Caplan Y.H. Abused Drugs Monograph Series 1994 Abbott Laboratories Irving, Texas
30. Karch S.D. Hallucinogens The Pathology of Drug Abuse 2nd ed. 1996 CRC Press Boca Raton 241
31. Kintz P. Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration J Anal Toxicol 21 1997 570
32. Kunsman G.W. Manno J.E. Cockerham K.R. Manno B.R. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxy-methamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine J Anal Toxicol 14 1990 149
33. Kuwahara T, Anderson DT: Endogenous gamma hydroxybutyrate (GHB) levels in postmortem specimens. California Association of Toxicologists Annual Meeting. Las Vegas, Nevada, November, 1997
34. Leikin J.B. Paloucek F.P. Poisoning & Toxicology Handbook 2nd ed. 1995 Lexi-Comp Inc. Hudson, Ohio
35. Maurer H.H. On the metabolism and the toxicological analysis of methylenedioxy-phenylalkylamine designer drugs by gas chromatography-mass spectrometry Ther Drug Monit 18 1996 465
36. McCann U.D. Ricaurte G.A. Major metabolites of (±) 3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons Brain Res 545 1991 279
37. McCann U.D. Ricaurte G.A. Lasting neuropsychiatric sequelae of (±) methylenedioxymethamphetamine (’Ecstasy’) in recreational users J Clin Psychopharmacol 11 1991 302
38. McKissick C: Rohypnol: The new date rape party drug of the 90s. US Department of Justice, Drug Enforcement Administration-Public Information pamphlet, 1996
39. Medrow K: Fact sheet: Rohypnol. Rockville, Maryland, Office of National Drug Control Policy Drugs & Crime Clearinghouse, September, 1996
40. National Coalition Against Sexual Assault Newsletter: New color-releasing formulation of Rohypnol announced at National NCASA meeting 1997 Ohio Cleveland
41. Osterloh J. Amphetamines Caplan Y.H. Abused Drugs Monograph Series 1994 Abbott Laboratories Irving, Texas
42. Poklis A. Fitzgerald R.L. Hall K.V. Saady J.J. EMIT-d.a.u monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA). Forensic Sei Int 59 1993 63
43. Radian International Inc. 4-Hydroxybutyric acid sodium salt: Standard Certificate of Analysis. Compound Lot No. 31544-31A
44. Rochholz G. Ahrens B. Schütz H. Modified screening procedure with fluorescence detection for flunitrazepam and its metabolites via acridine derivatives Drug Res 44 1994 469
45. Ropero-Miller J.D. Garside D. Goldberger B.A. Technical Brief Automated on-line hydrolysis of benzodiazepines improves sensitivity of urine screening by a homogeneous enzyme immunoassay. Clin Chem 43 1997 1659
46. Salt P. Public health Rave review. Nurs Times 89 1993 36
47. Saum C.A. Inciardi J.A. Rohypnol misuse in the United States Subst Use Misuse 32 1997 723
48. Sternbach G.L. Varon J. Designer drugs Recognizing and managing their toxic effects. Postgrad med 91 1992 169
49. Sumirtapura Y.C. Aubert C. Coassolo P. Determination of 7-amino-flunitrazepam (Ro 20-1815) and 7-amino-desmethylflunitrazepam (Ro 5-4650) in plasma by high-performance liquid chromatography and fluorescence detection J Chromatogr 232 1982 111
50. Woods J.H. Winger G. Abuse liability of flunitrazepam J Clin Psychopharmacol 17 1997 1S